Instructions for Authors: Journal of Clinical Immunology and Therapy

Image

Journal of Cancer Immunology and Therapy is a peer-reviewed, open access journal that reflects articles on all types of tumor immunology. The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.

Guidelines for Authors

All authors of accepted manuscripts warrant that the manuscript is original and has not been submitted for publication or published elsewhere. All the authors further warrant that, where necessary, they have obtained necessary releases from companies or individuals involved in or with the manuscript. All authors further warrant that the undersigned are the sole authors of this work. All authors hereby authorize the Allied Academies to publish the manuscript in the aforementioned Journal and, in consideration of the publication of the manuscript, agree to hold the Allied Academies, its assigns, affiliates, subsidiaries, officers, employees, directors and agents harmless and agree to defend the Allied Academies, its assigns, affiliates, subsidiaries, officers, employees, directors and agents in any action for damages which might arise as a direct or indirect result of the publication of the manuscript and to defend the Allied Academies, its assigns, affiliates, subsidiaries, officers, employees, directors and agents from third party liability associated with the manuscript and its publication. In consideration of the publication of the manuscript, all authors expressly assign ownership of the copyright and all rights to the manuscript to Allied Academies, and all authors expressly grant to Allied Academies, or its assigns, affiliates, subsidiaries, officers, employees, directors or agents: 1. The right to edit, clarify and shorten the manuscript, if the Allied Academies deems it necessary; and, 2. The right to republish, amend and summarize all or part of the manuscript in any compilation of manuscripts which the Allied Academies might publish, and, 3. The right to make the manuscript and the journal in which it is published available to databases, or distributors which might be involved in disseminating manuscripts or journals to various audiences.

You may submit manuscripts as an email attachment to the e-mail id cancerimmunol@eclinicalsci.com 

Media Contact,

Shelley Brown
Editorial Team
Journal of Cancer Immunology and Therapy
Email: cancerimmunol@eclinicalsci.com 
Whats App: +1-97-333-4405